sameAs
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencingRandomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malariaGametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian childrenGenome-wide and fine-resolution association analysis of malaria in West AfricaTools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria?Dermatophytosis among Schoolchildren in Three Eco-climatic Zones of MaliElusive Plasmodium Species Complete the Human Malaria Genome SetIntermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trialPopulation genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assaySurveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesMonitoring parasite diversity for malaria elimination in sub-Saharan AfricaCharacterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence DataNew var reconstruction algorithm exposes high var sequence diversity in a single geographic location in MaliDelayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali.The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient dataBaseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum.An effective method to purify Plasmodium falciparum DNA directly from clinical blood samples for whole genome high-throughput sequencing.A molecular marker for chloroquine-resistant falciparum malaria.Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali.Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa.PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation.Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali.Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.Broadening Participation in the Sciences within and from Africa: Purpose, Challenges, and Prospects.A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains.Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in MaliFirst detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from cutaneous leishmaniasis foci in MaliPolymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates.Intermittent preventive treatment using artemisinin-based combination therapy reduces malaria morbidity among school-aged children in Mali.A molecular map of chloroquine resistance in MaliAssessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malariaPlasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotype.In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipineEfficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in MaliComparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study.Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults.Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria
P50
Q20901697-C4D9C303-044E-42DD-A26F-0D58D5A9977DQ21034136-FF6DC897-CD1D-4509-BEF1-D05480094FE8Q22773191-4C7DF87E-2FB0-485A-AD86-3FB3F0C326A3Q24632119-8677BD87-13DC-4F86-BD74-C328049E23B4Q26765029-0B545ACD-FDEA-467B-82ED-7F2ED5F4D64DQ27303683-13EAC7DA-5816-4B73-9C68-D6118F5702E2Q28030927-38DA3164-0999-4D58-9FC6-2D00EC27794DQ28477050-5B98F9F1-5F37-498F-8DE5-ABD25236AD5DQ28478444-5FF66898-6700-4F76-B58E-6CDA009B0DE3Q28534753-31BA41FE-B12B-4588-8970-E798038D499FQ28610494-4A3EBE72-211B-4577-AC58-66FE028563D5Q30303389-3606C6F5-F132-46D2-B3C7-61451E076F2FQ30303389-8C7096A3-3DE0-4C91-AA5B-7A34A6A0B13FQ30843121-897920C2-D059-4A95-A77D-E74E7357950DQ30850979-0B28DB36-78BA-4A5A-9BFF-E4DEA33A34A4Q30936416-3219C882-6F1C-455A-9FD7-AAFB77E303A2Q30995133-78E3835D-ABEC-4A3B-BA77-95AFE180BC4CQ31000158-2B865170-1E2D-4BF0-B9A5-3E9A87079C8CQ31077064-A6F1757A-2F71-44B2-A6EC-1D9A88E6BCE5Q31921233-923EBF1E-089B-483C-AE63-736A60D55C49Q33278087-2A04A705-2DEB-4FB0-8B85-25A7756D2182Q33399342-694BDAAF-0CB5-4A9A-8C6C-E31632A7104CQ33596068-3A8C6E2D-9D4C-42E8-9AC4-ABFD10EA4F51Q33645358-1B8F7995-A93D-4A23-A256-1AE719D1A5F9Q33654911-5BFDDB77-011F-4270-B524-9841A5DF9466Q33764017-E881DC7F-F3B9-4263-BF0A-6D1F969DEF6EQ33848880-67D91797-09E5-4A38-A4DD-10E650CBC97AQ34083032-DA38541C-4158-45C8-9ABB-43CD5131D042Q34140111-BFB4C54F-9DD2-4FA7-9A1D-6DC88A55DFDEQ34281680-1EC564F5-0E92-4D64-8C5A-0BB88C31B82CQ34398049-2D74F5E1-A485-4D96-ADC7-906DD30FE340Q34563548-29A9B911-38D9-424D-AA2F-3607335C706FQ34572538-1C91E7CC-88C9-4C34-95B4-9569F6DD5FFAQ34630382-422495B0-EE5F-4B16-B069-A95A9F5B59C7Q34968407-BC60842D-A57F-4D97-A531-82957A25C45FQ35047872-9DEC6963-C8D0-4446-8381-52DD3FDB7E8CQ35065754-252229C6-5117-4E11-BD0C-58F40608C70CQ35078892-21B91751-6EF6-4A70-873F-8B9248597022Q35175033-19EC6D4D-66B1-4686-A530-2546705FEA48Q35190340-967EB7F7-FF5D-4879-BF8A-3D81218A41F0
P50
description
hulumtues
@sq
onderzoeker uit Mali
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Abdoulaye A. Djimde
@en
Abdoulaye Djimde
@ast
Abdoulaye Djimde
@es
Abdoulaye Djimde
@nl
Abdoulaye Djimde
@sl
Abdoulaye Djimdé
@de
Abdoulaye Djimdé
@fr
Джимбе, Абдулай
@ru
type
label
Abdoulaye A. Djimde
@en
Abdoulaye Djimde
@ast
Abdoulaye Djimde
@es
Abdoulaye Djimde
@nl
Abdoulaye Djimde
@sl
Abdoulaye Djimdé
@de
Abdoulaye Djimdé
@fr
Джимбе, Абдулай
@ru
altLabel
A A Djimde
@en
A A Djimdé
@en
A Djimde
@en
A Djimdé
@en
A. A. Djimde
@en
A. A. Djimdé
@en
A. Djimde
@en
A. Djimdé
@en
Abdoulaye A. Djimdé
@en
Abdoulaye Djimde
@en
prefLabel
Abdoulaye A. Djimde
@en
Abdoulaye Djimde
@ast
Abdoulaye Djimde
@es
Abdoulaye Djimde
@nl
Abdoulaye Djimde
@sl
Abdoulaye Djimdé
@de
Abdoulaye Djimdé
@fr
Джимбе, Абдулай
@ru
P106
P1960
Bo9WHSAAAAAJ
P2002
P21
P214
35153061219519200437
P27
P31
P7859
viaf-35153061219519200437